20 likes | 243 Views
PCSK9 targeting for the treatment of dyslipidemia. reduction of the PCSK9 mRNA I nhibition of the LDLR/PCSK9 binding at the plasma membrane Inhibition of the PCSK9 processing Inhibition of the intracellular LDLR/PCSK9 binding. 1.
E N D
PCSK9 targeting for the treatment of dyslipidemia reduction of the PCSK9 mRNA Inhibition of the LDLR/PCSK9 binding at the plasma membrane Inhibition of the PCSK9 processing Inhibition of the intracellular LDLR/PCSK9 binding 1 Tibolla G, et al., Nutrition, Metabolism & CardiovascularDiseases (2011, doi:10.1016/j.numecd.2011.06.002